Skip to search.
 FTSE 100 Down 0.58%

Alkermes plc (ALKS)

-NasdaqGS
63.33 Up 0.39(0.62%) 27 Mar 20:00
|After Hours: : 63.33 Down 0.01 (0.02%) 27 Mar 20:12
Add to Portfolio
Prev Close:62.94
Open:61.33
Bid:60.00 x 100
Ask:N/A
1y Target Est:69.55
Beta:1.31
Earnings Date:27 Apr - 1 May (Est.)
Day's Range:61.33 - 63.73
52wk Range:38.49 - 75.17
Volume:1,436,594
Avg Vol (3m):1,550,160
Market Cap:9.38b
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSUp 0.62%9.38b
ABTUp 0.60%70.59b
LLYUp 0.19%78.04b
GSKUp 0.77%113.11b

Key Statistics

Forward P/E (1 yr):1,266.60
P/S (ttm):15.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.34
Quarterly EPS Est (Mar-15) :-0.03
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-26.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback